# Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

> **NCT07378956** · NA · RECRUITING · sponsor: **VUNO Inc.** · enrollment: 340 (estimated)

## Conditions studied

- Diabetic Retinopathy (DR)
- Diabete Mellitus
- Fundus Photography

## Interventions

- **DEVICE:** VUNO Med®-Fundus AI™

## Key facts

- **NCT ID:** NCT07378956
- **Lead sponsor:** VUNO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-07
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07378956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07378956, "Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07378956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*